KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Gsk (GSK) over the last 17 years, with Q2 2025 value amounting to 0.02.

  • Gsk's Equity Ratio changed N/A to 0.02 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.02, marking a year-over-year change of. This contributed to the annual value of 0.22 for FY2024, which is 271.07% down from last year.
  • Gsk's Equity Ratio amounted to 0.02 in Q2 2025.
  • Gsk's Equity Ratio's 5-year high stood at 0.23 during Q4 2023, with a 5-year trough of 0.02 in Q1 2021.
  • Over the past 5 years, Gsk's median Equity Ratio value was 0.19 (recorded in 2021), while the average stood at 0.15.
  • As far as peak fluctuations go, Gsk's Equity Ratio plummeted by 741.74% in 2022, and later skyrocketed by 2837.42% in 2023.
  • Quarter analysis of 5 years shows Gsk's Equity Ratio stood at 0.19 in 2021, then dropped by 7.42% to 0.18 in 2022, then grew by 28.37% to 0.23 in 2023, then dropped by 2.71% to 0.22 in 2024, then crashed by 89.66% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q2 2025, 0.22 for Q4 2024, and 0.23 during Q4 2023.